Merck's Head Honcho "Unscripted" -- At Goldman, Sachs & Co. Tomorrow

As has become a tradition for the past three or four years, Merck's Chairman & CEO will speak, (theoretically) without a script, or "unplugged" as it was orginally known -- at Goldman's offices in Manhattan, tomorrow at 8:45 a.m., EST.

I'll live blog anything truly novel and/or material -- and note the conclusion of the reamrks, as well.

It would seem -- on balance -- that Merck's 2013 ought to be a stronger year, financially, than 2012 was -- now that the Singulair patent expiry is being lapped, quarter by quarter  Currencies ought to moderate, as well, in 2013.

In addition, the implementation of the ACA of 2010 should now result in the high hundreds of thousands of more US-based patients being able to afford Merck's pharmaceuticals effectively year-round -- not just until their respective Medicare "donut holes" are reached. So, all in all, it could be a good year ahead for the major multinational pharmas -- Whitehouse Station plainly included, here.

. . . .Kenneth C. Frazier, Merck's chairman and chief executive officer, is scheduled to present at the Goldman Sachs Healthcare CEOs Unscripted: A View from the Top meeting in New York City on Thursday, Jan. 3 at 8:45 a.m. EST. Investors, analysts, members of the media and the general public are invited to listen to a live audio webcast of the presentation. . . .

Merck will also report 2012 earnings on February 1, 2013. We will keep you posted.